Oral opioid treats rapid-onset 'breakthrough' pain
Epilepsy drug gets broader approval
Risk of blood clots in legs, lungs prompts label change for Ortho Evra patch
Immune-compromised are most at risk
Its heart-threatening effects emerge early and rise with dosage, research shows
No one has been harmed by tainted blood, the agency stressed
It's meant for patients with advanced heart disease who are too ill for transplant
Gestiva most effective before 35th week of pregnancy, researchers say
Gestiva most effective before 35th week of pregnancy, researchers say
Antibiotic widely prescribed for urinary and respiratory infections
Scientists spot mechanism allowing bisphenol-A to concentrate in tumor cells
Some say age restrictions won't limit teen pregnancies; others say contraceptive will boost promiscuity
Prescription for 'morning after' pill still required for younger females
FDA restricts access for those under 18; ruling follows three-year delay
Doctors are divided about yet-to-be-approved ArteFill
To prevent blocked arteries after heart attack
They subtly influence doctors' prescribing patterns, report contends
Already approved to increase bone mass in post-menopausal women
A popular antidepressant
FDA has issued warnings for one in every five devices, study finds
At issue is whether to make the contraceptive an over-the-counter drug
Once-daily application
They say the active ingredient doesn't work
They're chemically equal to pricier brand names
Hunter syndrome patients have trouble breaking down complex sugars
Contains novel UVA-blocking ingredient
Virus can cause death from chronic liver disease
Already sanctioned for several other malignancies
Implanon releases a low dose of the hormone progestin for up to three years
Lasts up to 3 years
FDA OKs Fuji's FCRm system
Among top-selling U.S. drugs
Retinal disease strikes thousands annually
Improved patient survival in trials
When standard therapy fails
Sprycel benefits patients resistant to other drugs, including Gleevec
Already sanctioned for Alzheimer's
Experts call the change overdue, given the accumulated evidence
2nd-best selling cholesterol drug in U.S.
Reduces span when symptoms return as medicines wear off
Extended survival by nearly 3 months
For people with history of the winter blues
But doesn't end need for Pap testing, FDA warns
They won't help patients, but could shield drug makers from legal action, researchers say
Restrictions apply after Tysabri was pulled from the market last year
It's recommended for those 60 years of age and older
Vaccine prevented 50 percent of cases in people older than 60
Prevents breakdown of key brain chemical
Bausch & Lomb's ReNu MoistureLoc linked to dangerous fungal infections
Chantix more effective than Zyban in clinical trials, agency says